: Paper on ‘Evaluating bone quality and bone mass in patients with Type 2 diabetes and oral glucocorticoid therapy: The Bushehr Elderly Health (BEH) program’
Presented by S. Gharibzadeh et al. from the Endocrinology and Metabolism Research Institute (EMRI – IR) during the 2020 Virtual World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO IOF-ESCEO) on 20-22.8.2020.
